doi: 10.2174/1871530319666190212170140
With both shortages now resolved, that pathway is no longer available for these medications
At each site, triplicate four-foot soil cores were collected, immediately placed on ice, and stored at -80C until analysis
2.2 Why India Matters as a Market India has: Over 77 million people with diabetes A rapidly growing obese and overweight middle class This makes India not only a low-cost manufacturing base, but also a large end-consumption market for advanced metabolic therapies
As a result, Novo Nordisk and Eli Lillys historical dominance will face its first real structural challenge, not from USA or European biotech startups, but from Indian and Chinese players scaling biosimilars and new molecular entities for export
Most weight-management clinics emphasize cardio or generic activity